MYC and cancer: We anticipate that miRNA therapy will blossom into an integral part of the precision medicine toolbox in the future, and hope that our identification of the miR-138:MYC interaction may launch new avenues for the targeting of the heterogeneous MYC transcript population and the subsequent treatment of MYC-driven cancers.